Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Re Takeover - They state 50.01% of the shares are not in public hands.
In any case any bidder would be stake building prior to a bid, once they reach
30% they are oblidged to make a bid.
So our votes won't count either way.
If it goes ahead Highway will be Aforti and we will be Aforti shareholders.
20 PLN is £4.05
Anyone with deep enough pockets to participate in the Placing are not
going to be selling 7 pence shares at below 7 pence.
MM's manipulating sp to flush out the nervous, day traders and trigger
stop losses on those daft enough to use them.
I see last year it was 11.00am in London.
This year 1.00pm GMT in New York.
Whilst AGM updates are usually none events in themselves, I am
wondering why it isn't in London this year.
Is it possible the AGM Update is to be followed by further a News Release.,
hence New York.
I am assuming the fund raising is already underway, which would
suggest if all goes well the meeting on 25th will just be a formality
and move quickly from there.
So an EGM shortly after 25th, probably at short notice, there cannot
be many shareholders - I am thinking perhaps less than 100.
After almost four years, whether it is 4 weeks or 8 weeks is of no consequence.
I am as keen as anyone else for a resolution to this situation.
With his holding currently at 29.75% I would say no.
If he were to exceed 30% under the rules he would be required to put
an offer in to buy the entire Company.
There are certain exceptions to that which probably would not apply.
We know Norris needed to prop up his new business in these difficult times.
Regarding DC Thompson the attached article was before Covid19 hit.
https://dailybusinessgroup.co.uk/2020/01/dc-thomson-profits-plunge-despite-sales-growth/
I don't imagine they are exactly awash with cash.
http://www.aptamergroup.co.uk/wp-content/uploads/2018/07/Aptamer-EBR-article-final.pdf
It shows that in July 2018 fourteen Companies Globally were in trials utilising Aptamers, the
majority Phase 1 and Phase 2.
Looking at the one most advanced Macugen - approved Phase 3 at that date it is currently in
use to treat a form of age-related macular degeneration.
https://www.bausch.com/ecp/our-products/rx-pharmaceuticals/rx-pharmaceuticals/macugen-pegaptanib-sodium-injection
https://www.halesowennews.co.uk/news/9544306.former-earls-pupils-22m-lifesaving-device-for-doctors/
No idea if this project progressed - they were looking at 3-5 years which would be 2017 at the latest.
It does show that Aptamer Group have been in the testing sector for many years and must
have a wealth of knowledge from their success and failure.
Interesting article which generates all kinds of questions.
Aptamer Group currently have one private company Melendor investing in them https://meneldor.nl/
In June 2018 Melendor of the Netherlands and with a Missouri connection ? advanced them $2.2 million.
Given we are almost two years on they look to have achieved a lot in the time and with 27 staff it does
suggest they are generating a significant revenue.
I have been invested since September 2018.
If you go to their website https://braveheartgroup.co.uk/ and look you
will see they have six major holding, Companies that they hold major stakes,
for example Paraytec 100%, Kirkstall 80% and Pharm2farm 51.72% .
They also have other investments, with reasonable holdings.
All these Companies are small, still developing and by their nature carry significant risk.
The Company had approaching a £1 million in cash and paid a Dividend following Court application
in Edinburgh, which permitted payment of that Dividend of 0.5 pence per share last October.
Early this year we saw the sp as low as & pence.
With Covid19 mania we have seen the sp at almost 50 pence and two cash raisings days apart,
first at 17 pence and then 22 pence - bringing around £500,000.
Now we are back around the 20 pence mark.
At the current sp it appears fairly valued, taking away any Covid19 link.
Should Paraytecs involvement with Aptamer Group https://uk.linkedin.com/in/arron-tolley-29887215
lead to any collaboration with major Pharma the sp would be many multiples.